This inventor holds 1 USPTO granted patent. Top assignee: Novartis Vaccines and Diagnostics Srl. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations by Vega Masiganani in Gonococcal Research
Introduction
Vega Masiganani is an accomplished inventor based in Siena, Italy. He has made significant contributions to the field of immunology, particularly in the development of vaccines and diagnostics for gonococcal infections. His work is characterized by a focus on proteins and nucleic acids derived from gonococcus.
Latest Patents
Vega holds a patent for "Gonococcal proteins and nucleic acids." This invention provides essential proteins from gonococcus, including amino acid sequences, corresponding nucleotide sequences, expression data, and serological data. The proteins are valuable antigens for vaccines, immunogenic compositions, and diagnostics. They also play a crucial role in distinguishing between gonococcus and meningococcus, especially between gonococcus and serogroup B meningococcus. He has 1 patent to his name.
Career Highlights
Vega Masiganani is currently associated with Novartis Vaccines and Diagnostics Srl, where he continues to advance research in vaccine development. His expertise in the field has positioned him as a key player in the fight against bacterial infections.
Collaborations
Vega has collaborated with notable colleagues, including Maria Rita Fontana and Elisabetta Monaci. Their combined efforts have contributed to the advancement of research in immunology and vaccine development.
Conclusion
Vega Masiganani's innovative work in gonococcal research highlights the importance of scientific advancements in public health. His contributions are paving the way for improved diagnostics and vaccines, ultimately benefiting society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile